Profiles

Claire Verschraegen

The Ohio State University Comprehensive Cancer Center

Verified email at osumc.edu

Cited by 13019

Rare Cancers Cancer Drug Development Translational Therapeutics

Frank Saran

University of South Australia

Verified email at sahmri.com

Cited by 11424

Rare cancers

Paola Ghiorzo

University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa

Verified email at unige.it

Cited by 9557

cancer genetics molecular bases of cancers melanoma rare cancers

Holly Barker

The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

Verified email at wehi.edu.au

Cited by 5586

tumour microenvironment hypoxia fibroblasts therapy resistance rare cancers

Gabriel MALOUF

Professor, Institut de Cancérologie de Strasbourg, IGBMC, ty

Verified email at icans.eu

Cited by 4199

Kidney Cancer Rare Cancers Epigenetics Genomics

MICHAEL STACEY

Old Dominion University

Verified email at odu.edu

Cited by 4119

membrane channels nuclear membrane pulsed electric fields rare cancers epigenetics

Jason Yongsheng Chan

National Cancer Centre Singapore

Verified email at nccs.com.sg

Cited by 2532

Lymphoma Sarcoma Melanoma Rare cancers Precision oncology

Christoph E. Heilig

Clinical and Research Fellow, Translational Medical Oncology, NCT Heidelberg

Verified email at nct-heidelberg.de

Cited by 2076

Molecular Cancer Diagnostics Precision Medicine in Oncology Rare Cancers Sarcoma

Michael Vincent Ortiz

Assistant Professor, Memorial Sloan Kettering Cancer Center

Verified email at mskcc.org

Cited by 1085

Pediatric Oncology Kidney Tumors Liver Tumors Rare Cancers Developmental Therapeutics

Chris Hemmings

Canterbury Health Laboratories

Verified email at member.rcpa.edu.au

Cited by 754

colorectal cancers sarcoma rare cancers neuroendocrine tumours GIST

1 - 10